Skip to content

Clinical Performance of All-ceramic Posterior Crowns. A Randomized, Prospective Clinical.

Clinical Performance of All-ceramic Posterior Crowns. A Randomized, Prospective Clinical Trial Comparing Glass-ceramic Crowns to Monolithic Translucent Zirconia Crowns With and Without a Semi-veneer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04272112
Enrollment
90
Registered
2020-02-17
Start date
2017-02-01
Completion date
2026-07-01
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Prosthesis Failure

Keywords

all ceramic, zirconia, crown, clinal trial

Brief summary

This is a randomized, prospective clinical trial. The aim of the project is to assess the clinical performance of three types of tooth-supported crowns; monolithic high translucent colored zirconia, crowns of high-translucent colored zirconia with a mini-veneer buccally and crowns of lithium-disilicate glass-ceramic. Crowns will be placed on posterior teeth and evaluated from an esthetic and functional point of view, to identify if there are any differences between the materials.

Detailed description

90 monolithic tooth-supported crowns are planned to be included in the study; 30 crowns of high translucent zirconia (BruxZir, Glidewell), 30 crowns of high translucent zirconia (BruxZir, Glidewell) with a mini-veneer of porcelain and 30 crowns of lithium-disilicate glass-ceramic (IPS e.max CAD, Ivoclar Vivadent AG, Schaan, Liechtenstein). Patients with indications for single crowns will be recruited from three general dental clinics. Inclusion criteria for participating in this study are patients in need of crowns in the posterior dentition, premolars and molars. Exclusion criteria are patients with high caries activity/risk for caries and/or advanced periodontal disease. Patients who meet the criteria will be offered the opportunity to participate in the study. They will receive written information about the study design, clinical procedures and the materials and methods to be used. Patients who are interested will confirm their participation by a written consent. The patients will be offered an extended warranty for the crowns in case of failure. The study has been approved by the Regional Ethical Board in Lund, Sweden

Interventions

COMBINATION_PRODUCTIPS e.max CAD, Ivoclar Vivadent

Type: monolithic lithium-disilicate glass ceramic

COMBINATION_PRODUCTBruxZir, Glidewell

Type: high translucent zirconia

COMBINATION_PRODUCTBruxZir*, Glidewell

Type: high translucent zirconia with a mini-veneer of porcelain

Sponsors

Malmö University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* need of one or more dental crowns in the posterior dentition, premolars and molars

Exclusion criteria

* high caries activity/risk for caries and/or advanced periodontal disease

Design outcomes

Primary

MeasureTime frameDescription
Clinical perfomance12 monthTo identify if there are any differences between the materials. The marginal integrity and surface will be rated as excellent, acceptable, retrievable or not acceptable according to a modified California Dental Association (CDA) quality assessment system.
Clinical performance120 monthsTo identify if there are any differences between the materials. The marginal integrity and surface will be rated as excellent, acceptable, retrievable or not acceptable according to a modified California Dental Association (CDA) quality assessment system.

Secondary

MeasureTime frameDescription
Patient questionnaire12 monthSelf-reported satisfaction with their treatment from 0 ('not satisfied at all') to 10 ('completely satisfied').

Countries

Sweden

Contacts

STUDY_CHAIRChristel Larsson, PhD

Malmö University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026